Dias-Ferreira, João
Claim profile
![](/image/cris/bar-loader.gif)
Credit Name
Dias-Ferreira, João
Name
Dias-Ferreira, João
Variants
Dias-Ferreira, João
Ciência ID
Scopus Author ID
Researcher ID
Status
UC Researcher
Biography
João Dias Ferreira holds a Pharm.D. (MSc in Pharmaceutical Sciences) from the Faculty of Pharmacy, University of Coimbra (FFUC) since September 2017.
During his 5-year course, he attended several positions both inside and outside FFUC. He was also involved in research projects concerning the Department of Pharmaceutical Chemistry - where he devoted his time to the design and synthesis of new aromatase and 5-alpha reductase inhibitors for breast cancer treatment and new polyphenolic antioxidant compounds for neurodegenerative disorders treatment - and Pharmaceutical Technology, where he developed new formulations regarding their applications in fields as oncology and cosmetics.
In the last two years of his course, he had the chance to embrace a project at iCBR-FMUC (University of Coimbra), at Biophysics Unit, regarding the application of new 4 very promising photosensitizers in the treatment of melanoma in the context of Photodynamic Therapy, where he developed his researcher aptitudes concerning cell culture, in vitro cell-assays, flow cytometry, and other techniques. Ultimately this project leads to his final course thesis entitled "Advances on photodynamic therapy: new pyridine-fused diphenylchlorins as new photosensitizers for melanoma treatment".
From February 2018 to September 2019 he was a fellowship-holder in FFUC at the Department of Pharmaceutical Technology, in the field of Nanotechnologies applied to Health.
By September 2019 he started the Integrated Master in Medicine at the Faculty of Medicine of the University of Porto.
During his 5-year course, he attended several positions both inside and outside FFUC. He was also involved in research projects concerning the Department of Pharmaceutical Chemistry - where he devoted his time to the design and synthesis of new aromatase and 5-alpha reductase inhibitors for breast cancer treatment and new polyphenolic antioxidant compounds for neurodegenerative disorders treatment - and Pharmaceutical Technology, where he developed new formulations regarding their applications in fields as oncology and cosmetics.
In the last two years of his course, he had the chance to embrace a project at iCBR-FMUC (University of Coimbra), at Biophysics Unit, regarding the application of new 4 very promising photosensitizers in the treatment of melanoma in the context of Photodynamic Therapy, where he developed his researcher aptitudes concerning cell culture, in vitro cell-assays, flow cytometry, and other techniques. Ultimately this project leads to his final course thesis entitled "Advances on photodynamic therapy: new pyridine-fused diphenylchlorins as new photosensitizers for melanoma treatment".
From February 2018 to September 2019 he was a fellowship-holder in FFUC at the Department of Pharmaceutical Technology, in the field of Nanotechnologies applied to Health.
By September 2019 he started the Integrated Master in Medicine at the Faculty of Medicine of the University of Porto.
![](/image/cris/bar-loader.gif)
Publications
(All)
Results 1-5 of 5 (Search time: 0.343 seconds).
Issue Date | Title | Author(s) | Type | Access | |
---|---|---|---|---|---|
1 | 1-Jun-2020 | Carta ao editor: O papel dos estudantes de medicina na pandemia de COVID-19 em Portugal | Gi, Andreia ; Rodrigues, Bárbara; Dias-Ferreira, João ; Faria, João ; Pedro, João Fernandes; Oliveira, João ; Viegas, Maria H.; Ribeiro, Marta | article | openAccess |
2 | 9-Sep-2021 | Elastic and Ultradeformable Liposomes for Transdermal Delivery of Active Pharmaceutical Ingredients (APIs) | Souto, Eliana ; Macedo, Ana S; Dias-Ferreira, João ; Cano, Amanda ; Zielińska, Aleksandra ; Matos, Carla M. | article | openAccess |
3 | 2021 | Encapsulation of Active Pharmaceutical Ingredients in Lipid Micro/Nanoparticles for Oral Administration by Spray-Cooling | Favaro-Trindade, Carmen S.; Matos Junior, Fernando E. de; Okuro, Paula K.; Dias-Ferreira, João ; Cano, Amanda; Severino, Patricia; Zielińska, Aleksandra ; Souto, Eliana | article | openAccess |
4 | 11-Feb-2020 | Nanopharmaceutics: Part I-Clinical Trials Legislation and Good Manufacturing Practices (GMP) of Nanotherapeutics in the EU | Souto, Eliana B. ; Silva, Gabriela F.; Dias-Ferreira, João ; Zielińska, Aleksandra ; Ventura, Fátima; Durazzo, Alessandra; Lucarini, Massimo; Novellino, Ettore; Santini, Antonello | article | openAccess |
5 | 2021 | Open-Air Cold Plasma Device Leads to Selective Tumor Cell Cytotoxicity | Almeida-Ferreira, Catarina ; Silva-Teixeira, Rafael ; Laranjo, Mafalda ; Almeida, Nuno ; Brites, Gonçalo ; Dias-Ferreira, João ; Marques, Inês A. ; Neves, Rita ; Serambeque, Beatriz ; Teixo, Ricardo ; Abrantes, Ana Margarida ; Caramelo, Francisco ; Botelho, Maria Filomena | article | openAccess |